default author photo

Filippo Spriano

affiliation not provided to SSRN

SCHOLARLY PAPERS

2

DOWNLOADS

132

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

RS6077 Induces Mitotic Arrest and Selectively Activates Cell Death in Human Cancer Cell Lines and in a Lymphoma Tumor In Vivo

Number of pages: 21 Posted: 30 May 2022
Sapienza University of Rome - Department of Chemistry and Drug Technologies, Sapienza University of Rome - Department of Chemistry and Drug Technologies, Sapienza University of Rome - Department of Chemistry and Drug Technologies, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, USI - Faculty of Biomedical Sciences, Sapienza University of Rome - Department of Chemistry and Drug Technologies and Sapienza University of Rome - Department of Chemistry and Drug Technologies
Downloads 104 (674,591)

Abstract:

Loading...

Tubulin, Mitotic arrest, Lymphoma, Pyrrole, Synthesis

2.

Pharmacological inhibition of CXCR4 increases the anti-tumor activity of conventional and targeted therapies in B-cell lymphoma models

Number of pages: 46 Posted: 10 Mar 2026
University of Turin, Department of Law, affiliation not provided to SSRN, Institute of Oncology Research (IOR), affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Oncology Institute of Southern Switzerland, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 28 (1,399,036)

Abstract:

Loading...

CXCR4 inhibition, Drug resistance in B-cell lymphoma, BTK inhibitor synergy, NF-κB/AKT/MYC signaling pathways, Chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL)